Diabetic patients receiving bare-metal stents: No option patients?

Journal of the American College of Cardiology

Volumn 61, Issue 16, 2013, Pages 1686-1687

  Strauss, Bradley H ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

bare metal stent(s); diabetes; in stent restenosis; intravascular ultrasound; neointima

Indexed keywords

COLCHICINE; INSULIN; PACLITAXEL; PLACEBO;

ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CLINICAL DECISION MAKING; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; DUAL ANTIPLATELET THERAPY; GLYCEMIC CONTROL; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; LONG TERM CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION;

EID: 84876229298     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.056     Document Type: Editorial

References (14)

1. N.E. West, P.N. Ruygrok, C.M. Disco Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients Circulation 109 2004 867 873
2. G.N. Levine, E.R. Bates, J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention J Am Coll Cardiol 58 2011 e44 e122
3. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) W. Wijns, P. Kolh, N. Danchin et al. Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
4. A.L. Dans, S.J. Connolly, L. Wallentin Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial Circulation 127 2013 634 640
5. B.-K. Kim, M.-K. Hong, D.-H. Shin A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) J Am Coll Cardiol 60 2012 1340 1348
6. B. Witzenbichler Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins? J Am Coll Cardiol 60 2012 1349 1351
7. M.K. Natarajan, B.H. Strauss, M. Rokoss Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes The STent Restenosis And Metabolism (STREAM) study Cardiovasc Revasc Med 13 2012 95 100
8. R.M. Ali, R. Degenhardt, R. Zambahari Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus EuroIntervention 7 Suppl K 2011 K83 K92
9. R.A. Byrne, F.J. Neumann, J. Mehilli ISAR-DESIRE 3 investigators Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
10. J. Wöhrle, M. Zadura, S. Möbius-Winkler SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study J Am Coll Cardiol 60 2012 1733 1738
11. S. Deftereos, G. Giannopoulos, R. Konstantinos Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients J Am Coll Cardiol 61 2013 1679 1685
12. J.H. O'Keefe Jr., B.D. McCallister, T.M. Bateman, D.L. Kuhnlein, R.W. Ligon, G.O. Hartzler Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty J Am Coll Cardiol 19 1992 1597 1600
13. M. Freed, R.D. Safian, W.W. O'Neill, M. Safian, D. Jones, C.L. Grines Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty Am J Cardiol 76 1995 1185 1188
14. P. Woudstra, P. Damman, M.A. Beijk Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis Catheter Cardiovasc Interv 81 2013 26 33